Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Locally Advanced Cervical Cancer × Gemcitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 579 Carcinoma, Non-Small-Cell Lung 274 Breast Neoplasms 138 Neoplasms 135 Urinary Bladder Neoplasms 132 Lung Neoplasms 132 Neoplasm Metastasis 115 Cholangiocarcinoma 95 Ovarian Neoplasms 82 Biliary Tract Neoplasms 78 Nasopharyngeal Carcinoma 64 Lymphoma, Large B-Cell, Diffuse 63 Lymphoma 56 Recurrence 54 Sarcoma 53 Gallbladder Neoplasms 53 Carcinoma, Transitional Cell 44 Hodgkin Disease 42 Colorectal Neoplasms 41 Lymphoma, Non-Hodgkin 40 Triple Negative Breast Neoplasms 38 Adenocarcinoma 38 Fallopian Tube Neoplasms 37 Bile Duct Neoplasms 36 Non-Muscle Invasive Bladder Neoplasms 27 Carcinoma 27 Uterine Cervical Neoplasms 26 Carcinoma, Ovarian Epithelial 26 Unspecified Adult Solid Tumor, Protocol Specific 24 Urethral Neoplasms 22

Interventions

Cisplatin 6 Radiotherapy 3 Paclitaxel 2 Carboplatin 2 Brachytherapy 2 zimberelimab 1 piperine 1 pembrolizumab 1 durvalumab 1 camrelizumab 1 atezolizumab 1 Neoadjuvant Therapy 1 Gemcitabine 1 Drug Therapy 1 Curcumin 1 Chemoradiotherapy 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06156514 2025-05-28

MICHELE

National Institute of Cancerología

Phase 3 Recruiting

Locally Advanced Cervical Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡